Human 6-sulfo LacNac-positive (slan + ) cells have been subject to a paradigm debate. They have previously been classified as a distinct dendritic cell (DC) subset. However, evidence has emerged that they may be more related to monocytes than to DCs. 
Introduction
Human slan + cells have been described both as part of the DC compartment and as a member of the CD16 + monocytes. They were first described by Schäkel et al. [1, 2] as a unique circulating blood DC subset expressing a carbohydrate modification of the P-selectin glycoprotein ligand 1, slan, recognized by the antibody M-DC8. M-DC8 + cells displayed immunophenotypic and functional features in common with other human blood DC subsets and were therefore named slanDC [3] . In line with their high expression levels of FcgRIII (CD16) and FcgRII (CD32), slan + cells were found to be involved in ADCC [4] . Furthermore, an important role in anti-tumor responses has been shown, as slan + cells contribute to the killing of tumor cell lines and the activation of tumor-directed cytotoxic NK cells [5] . Their high proinflammatory character is also demonstrated by their ability to produce high levels of IL-12 and TNF-a and their recruitment in chronic inflammatory diseases [2, 3, [6] [7] [8] .
DC subsets form a heterogeneous group of cells with a wide functional diversity [9] [10] [11] [12] [13] [14] [15] . The variance in expression of pattern recognition receptors, such as TLRs and C-type lectin receptors, indicates a unique function for each DC subset [6, 16, 17] . Various studies have compared slan + cells with conventional myeloid blood DC subsets (CD1c + and CD141 + ) to investigate their DC-like activity [2, 3, 6, 8, 18] . These reports have shown conflicting results regarding the cytokine production and T cellstimulatory capacity of slan + cells [3, 18] . Recently, Nizzoli et al. [18] suggested that these discrepancies could be a result of diverse activation stimuli used in these studies. They showed that the secretion of IL-12, for instance, relies on a synergistic TLR stimulation with LPS and R848. Another factor in this controversy may well be the variation in the immunophenotypic definition of slan + cells. Previous studies have compared CD16 + DC with conventional DC subsets, without the use of M-DC8 as a specific marker for slan + cells. Transcriptional profiling demonstrated a distinct gene signature for these CD16 + DC/monocytes. They clustered together with other monocytes subsets, indicating a closer relationship to monocytes than to conventional DCs [12, 14, [19] [20] [21] . Recently, Hofer et al. [22] showed that the use of slan antibodies allowed for the discrimination between two monocyte populations: the intermediate and non-classical monocytes. Based on unsupervised hierarchical clustering, slan + non-classical monocytes were separated from CD1c + DCs, confirming previous findings that slan + cells are more related to monocytes than to DCs. However, functional correlates with this new nomenclature and their relationship with the other conventional DC subset (CD141 + DC) remain unexplored.
The contribution of inflammatory myeloid cell subsets, including that of slan + cells, to the development of various immune-mediated diseases has been described before. A deeper insight into normal DC/monocyte biology is essential, eventually to increase our knowledge on and offer new therapeutic targets for these immune-related diseases. Additionally, the elucidation of DC-like activities of defined cell subsets is of high interest in, for example, DC-targeted tumor immunotherapy. Thus, with the consideration of the variability in experimental setup and the inconsistent results in relation to DC-like functionalities of slan + cells from previous studies, we have now performed a comparative study of slan + cells and both conventional myeloid CD1c + and CD141 + DC subsets in human PB. A detailed genome-wide transcriptional analysis was carried out encompassing all three subsets, based on which subsequent functional analyses confirmed a distinct role for slan + cells. Whereas the myeloid DC subsets are able to induce and imprint functionality on primary T cell responses, slan + cells harbor phenotypic and functional traits consistent with the amplification and support of innate inflammatory responses. In addition, with the comparison of our gene-expression data with the expression profiles of monocyte and DC subsets from existing data sets, we clearly show that transcriptional profiles of slan + cells overlap with the CD16 + non-classical monocytes rather than with CD1c + DCs, and we therefore support the designation of slan + cells as non-classical monocytes.
MATERIALS AND METHODS

Sample preparation and DC isolation and sorting
Buffy coats from HDs were obtained after written, informed consent from Sanquin blood supply services (Amsterdam, The Netherlands). PBMCs were isolated by density centrifugation using Ficoll-Paque medium. 
Microarray data analysis
Microarray signals were normalized using the robust multiarray average algorithm in the Affymetrix Expression Console software (Thermo Fisher Scientific ), and quality checks were performed. For the correction of background noise, probe sets were excluded if 20% or more of the samples showed levels below the median of negative control intensities, unless 4 out of 4 samples from 1 population showed levels above the median of control. Qlucore Omics Explorer 3.2 (Qlucore AB, Lund, Sweden) was used for transcript filtering and to find DEGs by performing an ANOVA analysis and using Q values of ,0.05. Pathway and network analyses were performed in MetaCore (Thomson Reuters, New York, NY, USA) or in STRING v10.0. For heat map visualization, Perseus software was used, and Z-scores were calculated per transcript for each donor, thereby generating relative expression levels.
To compare the generated gene-expression profiles with an existing data set [19] , a cross-study normalization tool was used [23] , and data were normalized using the empirical Bayes method [24] . The combined data set was then uploaded into the Perseus software program. Subsequent data transformation was performed by using Z-scores for each transcript. Additionally, a multiple sample test (ANOVA) was applied, and differentially expressed transcripts were identified. With the use of these transcripts, hierarchical clustering was performed, and cell subsets were further divided into 3 clusters by K-means clustering. The microarray data, including the normalized file from the cross-study analysis, have been deposited in the GEO public database under Accession Number GSE98694.
Overnight maturation and cytokine secretion assay
Baseline expression levels of CD80, CD86, and HLA-DR were evaluated before isolation of cell subsets. After isolation, cells were preincubated for 4 h in IMDM, supplemented with 10% FCS, 100 IU/ml penicillin, and 100 mg/ml streptomycin (all Gibco, Paisley, United Kingdom) in a 96-well plate at 1 Fig. 3A ). Culture supernatants were collected and analyzed for the presence of different cytokines and anaphylatoxins using human enhanced sensitivity CBA flex sets or the human anaphylatoxin CBA kit (both BD Biosciences).
Allogeneic MLR
Allogeneic MLRs were performed as described previously [25] . Genome-wide transcriptional profiling delineates the relationship between slan + cells and myeloid DC subsets
To gain deeper insight in the function of slan + cells in relation to conventional myeloid DCs, extensive genome-wide transcriptional profiling was carried out on these 3 cell types. After background correction, 58,457 genes were found to be expressed. With the use of all expressed transcripts, a PCA showed an adequate similarity of the defined subsets in the different donors (n = 4). Furthermore, minimal spanning-tree analysis revealed a close relationship of the 2 conventional CD1c + and CD141
+ myeloid DC subsets but not of the slan + cells, which clustered away from the 2 DC subsets and formed a distinct segregated population ( Fig. 2A) . To look further into DEGs for all 3 subsets, an ANOVA analysis was performed. This analysis yielded 4611 differentially expressed transcripts that could discriminate the subsets, and the PCA again showed excellent similarity for each subset among different donors ( Fig. 2A) . Hierarchical clustering performed on DEGs also showed that CD1c + and CD141 + DCs clustered closer together, and slan + cells formed a separate branch (Fig. 2B ).
Unique gene-expression profiles for slan + cells and CD1c + and CD141 + DCs
To find a unique gene-expression profile for slan + cells, transcripts that were differentially expressed in slan + cells compared with CD1c + and CD141 + were filtered and defined as slan-specific transcripts. Furthermore, CD1c-specific and CD141-specific transcripts were filtered in a similar manner. The highest number of unique transcripts was found for slan + cells, again indicating that this subset is less similar than the other 2 DC populations. In total, 1231 transcripts were found to be differentially expressed in slan + cells, whereas only 7 and 29 genes were unique to CD1c + and CD141 + DCs, respectively (Fig .   3A ). With the use of the logFC, relative levels of over-and underexpressed genes were discriminated. For slan + cells, 528 genes were significantly overexpressed as compared with the other 2 subsets, whereas 703 genes were expressed at lower levels. In CD1c + DCs, 6 genes showed significantly higher expression levels, and only 1 gene was underexpressed. Furthermore, for CD141 + DCs, only 1 gene was found to be expressed at lower levels compared with the other subsets, whereas 28 genes were overexpressed. Clustering analysis based on relative expression levels of the differentially expressed transcripts is presented in a heat map (Fig. 3B ). Consistent patterns were observed with low interdonor variability.
Pathway analysis shows specific immune-related functionality for slan + cells
We next set out to identify exclusive functional features of the slan + cells compared with the myeloid DC subsets. Genes highly Table 1 . At the top of this list, known slan-discriminating markers were found (including CD16a).
Clear differences in immunologic function between slan + cells and the conventional myeloid DC subsets could further be deduced from this list. Transcripts with immune-related functions were strongly represented, such as complement factors, FcgRs, the CSF1R, and a member of the inhibitory LILRB2. Further pathway analyses, using the whole data set, were executed to specify enriched pathways that were possibly involved in functional variances among the subsets. The pathway mostly enriched from the underexpressed gene list was designated "Immune response_Antigen presentation by MHC class II," indicating a lower capacity for antigen presentation in slan + cells compared with the conventional myeloid DC subsets ( Table 2) , in keeping with their lower surface expression of HLA-DR (Fig.  1C) . Significantly enriched pathways that were produced from the overexpressed gene list displayed a strong enrichment of genes involved in the complement cascade. All 3 complement pathways were highly enriched in slan + cells compared with CD1c + and CD141 + DCs (top 3 of enriched pathways in Table 2 ).
This finding, together with the fact that complement-associated transcripts were in the top 50 list with highest logFC values, supports the notion that this innate immune process evidently distinguishes slan + cells from the myeloid DC subsets.
The slan-specific gene-expression profile overlaps with CD16 + non-classical monocyte profiles from existing data sets
To confirm that slan + cells showed more overlap with the monocyte compartment than with DC subsets, we compared our own transcriptional data with previously published data sets, which included genome-wide transcriptional profiles of monocyte subsets. The list of overexpressed genes in slan + cells (of which 381/528 could be linked to known and coding genes) was compared with gene lists from 3 different studies [19, 22, 26] , all containing CD16 + and CD16 2 monocyte subsets. From these studies, DEGs between the monocyte subsets were listed. In the study of Hofer and colleagues [22] (data set was derived from the Blood website), 385 DEGs were found (using data from their slanbased isolation method), of which 160 DEGs were overexpressed in non-classical monocytes compared with intermediate monocytes (Fig. 4A) . (Fig. 4B ). In total, 34 genes could be found in all studies ( Table 3) . Next, the microarray data set of Frankenberger et al. [19] , containing both CD1c + DCs, as well as monocyte subsets, was used for detailed cross-study comparison with our own data set. As one of the CD16 2 monocyte replicates from the Frankenberger [19] data set was clearly identified as an outlier (Supplemental Fig. 2 ), this replicate was excluded from further analysis. Subsequently, both raw data files were merged by using ArrayMining [23] , a tool that allows the combination of microarray data sets by using parametric and nonparametric empirical Bayes methods, and the newly generated, combined data set was uploaded into Perseus software. In total, 19,170 transcripts could be matched between the data sets. After a multiple-sample ANOVA test and the removal of duplicates, 8877 DEGs were found. Hierarchical clustering clearly showed coclustering of the slan + cells with the CD16 + monocytes from the data set of Frankenberger et al. [19] . Both CD16 + as well as CD16 2 monocyte populations clustered away from DC subsets. Moreover, the 2 replicates of CD16 2 monocytes formed a separate branch within the monocyte populations. CD1c + DCs from both data sets and CD141 + DCs from our own set clustered together (Fig. 4C) . With the use of the 8877 DEGs, 4 sets of gene clusters were created by K-means clustering. In total, 1969 transcripts were up-regulated in CD16 + /slan + monocytes compared with CD16 2 monocytes, CD1c + DCs, and CD141 + DCs. From these transcripts, 285 were identical to the 528 transcripts that were already identified as specifically overexpressed by comparing slan + cells with CD1c + and CD141 + DCs in our initial microarray analysis and were therefore considered highly slan/ non-classical monocyte specific. Network analysis of these 285 genes in STRING v10.0 showed a strong enrichment in pathways involved in immune processes (Fig. 4D) (Fig. 5A) . Of note, similar results were observed for monocytes. Furthermore, cytokine secretion profiles of slan + cells, monocytes, and myeloid DCs were evaluated after isolation and overnight stimulation. The Th1-inducing cytokine IL-12p70 was primarily produced by CD1c + DCs and to a lesser extent, by CD141 + DCs but only after combinational TLR stimulation (Supplemental Fig. 3A) . Furthermore, intracellular staining of IL-12 in CD1c + DCs and monocytes confirmed the need for a combination of TLR ligands (Supplemental Fig. 3B ). slan + cells and monocytes secreted negligible amounts of IL-12p70, whereas these subsets both released relatively high levels of IL-1b and IL-6 (Fig. 5B) .
To test their ability to prime a T cell response, slan + cells were compared with the most prevalent myeloid DC subset (CD1c + ) and monocytes in an allogeneic MLR. Because of low cell numbers, we were not able to test CD141 + DCs in this regard. As measured by the percentage of CFSE dilution, CD1c + DCs displayed a superior capacity to induce T cell proliferation compared with slan + cells and monocytes (Fig. 5C ). This difference in induction capacity was most pronounced for CD4 + T cells in keeping with lower HLA-DR levels observed on slan + cells and monocytes. Altogether, these data provide strong evidence that slan + cells are less capable of T cell priming and differentiation induction than conventional myeloid DC subsets and show functional similarity to monocytes.
Unique role for slan + cells in the complement cascade
From the genome-wide transcriptional profiling, cellular pathways involving the complement cascade were found to be greatly enriched in slan + cells compared with conventional DCs. The presence of different complement receptors was therefore evaluated on unstimulated cell subsets in 3 whole PB samples. The predominant presence of CR1, C3aR, and C5aR on slan + cells compared with myeloid DC subsets indeed confirmed the gene-expression data (Fig. 6A) . Although replicate numbers are low, and results are near the detection limit of the test (0.45 pg/ml), the presence of complement components C3a and C5a in the supernatant of stimulated slan + cells and not in the supernatant of CD1c + DCs supports a unique involvement of this myeloid subset in complement-mediated responses (Fig. 6B) . However, their exact role in the complement cascade should be explored in more detail.
DISCUSSION
Functional characterization of different DC and monocyte subsets in steady-state and inflammatory conditions has led to contrasting outcomes in literature. The extension of our knowledge on these different human cell types will help us to understand their involvement in specific immune-mediated physiologic and pathologic processes. Therefore, we carried out a detailed transcriptional and functional study in which we directly compared conventional myeloid DCs (CD1c + and CD141 + ), monocytes, and slan + cells from PB of HDs.
Based on the expression of CD1c, CD141, CD14/CD16, and slan (M-DC8), different DC and monocyte subsets with distinct immunologic functions can be found within the CD11c + myeloid cell compartment [13, 27] . At the time of their discovery, slan + cells were categorized as part of the DC compartment and were shown to harbor DC-like functionalities, including antigen presentation and IL-12 production capacity. In comparative studies, slan + cells sometimes even showed superior DC-like functions compared with conventional DC subsets [3, 8] . However, in these studies, the different cell populations were stimulated under what we now know to be suboptimal conditions, i.e., with only 1 TLR ligand. Recently, the concept of slan + cells being a subset more related to monocytes than to DCs was proposed. Based on CD14 and CD16 expression, monocytes were subdivided into 3 different subsets: CD14 ++ CD16 2 "classical," CD14 ++ CD16 + "intermediate," and CD14 + CD16 ++ "non-classical" monocytes [28] . The dissection of intermediate and non-classical monocytes on the basis of CD14 and CD16 is rather arbitrary. Hofer et al. [22] showed that slan expression allowed for the strict discrimination between the 2 subsets in which intermediate monocytes were slan negative and non-classical monocytes slan positive. In keeping with this notion, furthermore, other studies have reported slan + cells to represent, most likely, a subset of monocytes [21, 29, 30] . Cros et al. [21] for instance, showed that slan + cells were closely related to mouse GR1 2 monocytesalready a strong indication that they might resemble non-classical CD16 + monocytes more than DCs. However, a direct transcriptional comparison with human DCs was not included in their strategy, and whereas Hofer and colleagues [22] transcripts related to antigen presentation were underrepresented. Consistent with the transcriptional data, complement receptors were all present at much higher surface levels on slan + cells compared with conventional DCs. Furthermore, the production of the complement factors C3a and C5a by slan + cells supports their unique involvement in complement-associated responses. Generally, the complement system is involved in innate immune responses, and several immune cells can contribute to the local complement pool. Engagement of C3aR or C5aR on DCs can lead to up-regulation of maturation markers and a higher potency to stimulate Th1 responses [31, 32] . In contrast, simultaneous stimulation of complement receptors and TLRs results in an impaired DC functionality [33] [34] [35] . The production of complement factors by slan + cells could imply a distinct role in immune reactions compared with conventional DCs. The involvement in complement-driven immune responses has been described as a common monocytic feature that is conserved among several vertebrate species. Different monocyte subsets showed higher gene-expression levels of complementassociated receptors compared with DCs in human, mouse, sheep, and pig, implying a strong preservation of this functionality [36] . One could hypothesize that slan + cells enlarge the local complement pool and attract innate immune cells for further amplification of the innate immune response. Furthermore, their complement components could serve as an essential element in adaptive immunity by enhancing T cell expansion and viability and B cell activation [37] [38] [39] [40] [41] . Finally, their high FcgRIII and complement receptor levels, allowing for efficient Fc-mediated IgG binding, single out the slan + cells as potent mediators of ADCC. Indeed, a case in point was recently provided by the finding that (slan + ) non-classical monocytes in patients with melanoma mediate ADCC-dependent elimination of T regs upon ipilimumab administration [42] . Danger signal-induced maturation and the subsequent acquisition of T cell priming capacity are regarded as defining features of the myeloid DC lineage. Consistent with their predominant monocytic nature, our data showed inferior maturation and antigen-presentation capacities of slan + cells (and CD14 + classical monocytes) compared with conventional DC subsets. Despite higher baseline-expression levels of CD80 and CD86, slan + cells and classical monocytes did not show an equivalent capability in up-regulation of these costimulatory markers to the conventional DC subsets. Furthermore, their expression level of HLA-DR was lower. In allogeneic MLRs, much lower CD4 + and CD8 + T cell proliferation was found in cultures with slan + cells or classical monocytes when compared with CD1c + DCs. This is in agreement with a previous report that compared CD14 dim CD16 + monocytes (substantially overlapping with slan + cells) with Pathway analysis of over-and underexpressed genes in slan + cells. Gene lists from over-and underexpressed transcripts were imported into the MetaCore bioinformatic tool, and significant enriched pathways were identified. The total number of genes in the specified pathway maps is shown, as well as the number of genes present in the dataset. The top 10 enriched pathway maps are given for both over-and underexpressed genes. No., Number; FDR, false discovery rate; PDGFs, platelet-derived growth factors; SLE, systemic lupus erythematosus; MIF, migration inhibitory factor; PKA, protein kinase; AVP, arginine vasopressin; PACAP, pituitary adenylate cyclase-activating polypeptide; ACM, acetylcholine muscarinic. We also studied cytokine profiles of the different myeloid cells upon combinatorial TLR-mediated stimulation. Cytokines have a polarizing function on T cells and eventually determine the functional outcome of an immune response. For instance, IL12p70 will mainly skew naive T cells into a Th1-type direction. DC subsets have a differential ability to produce a wide variety of cytokines. CD1c + DCs can produce high levels of IL-12 but only after a combinatorial stimulation of TLR4 and TLR7/8 [18] . The absence of IL-12 production in some studies could be explained from these studies were derived from the overlap found by comparing our own overexpressed gene-expression profile for slan + cells with the CD16 + nonclassical monocytes of the indicated study. In total, 34 genes were present in all studies. (C) A detailed cross-study comparison between our own current data set [N.v.L.-K. (vL)] and the data set from the study of Frankenberger et al. [19] (f). DEGs (8877; ANOVA with P , 0.05) were used for clustering analysis. Relative expression levels for a single transcript were calculated by using Z-scores (Z-score -2: low expression; Z-score 2: high expression). (D) Network analysis of 285 highly slan-specific proteins. The minimum required interaction score was set to highest confidence (0.900), and disconnected nodes were hidden. Functional signaling nodes are indicated. Overlapping genes derived from different existing data sets and our own study that show overexpression in slan + cells/CD16 + monocytes. a Ancuta et al. [26] .
b Hofer et al. [22] . c Frankenberger et al. [19] .
by the fact that only a single TLR ligand was used. Therefore, we explicitly recommend the use of synergistic TLR stimulation in comparative DC studies. With the use of this method, conventional DCs, slan + cells, and classical monocytes displayed different cytokine-secretion profiles. In contrast with other reports, in our hands, slan + cells were not the main producers of IL-12, but CD1c + DCs clearly exceeded them in this capacity. CD1c + DCs were also able to secrete equivalent levels of IL-6, IL-8, and TNF compared with slan + cells. Only the production of IL-1b was primarily found in slan + cells and classical monocytes. The simultaneous secretion of high levels of IL-1b and IL-6, uniquely observed for monocytic cell subsets (slan + cells and classical monocytes), could affect the fate and stability of lineagecommitted CD4 + T cells. Published data show that these 2 cytokines are both required for the induction of human Th17 differentiation from naive CD4 + T cells, whereas IL-12 blocks the polarization toward Th17 cells [43] . Furthermore, the stability of lineage-committed T cells can be affected by these cytokines. It Statistical differences were identified using a Kruskal-Wallis with Dunn's post-test. *P , 0.05; **P , 0.01; ***P , 0.001; ****P , 0.0001. has been shown that under certain conditions, T cells can be converted from one lineage to another, a phenomenon known as T cell plasticity. T regs , for instance, can become IL-17-producing cells in the presence of IL-1b and IL-6 [44] [45] [46] [47] . The cytokine secretion profile of slan + cells thus identifies them as a possible key population for the induction and support of proinflammatory Th17 immune responses. Although consistent with their previous assignation as a proinflammatory subset, it distinguishes them from conventional myeloid DCs.
In summary, our data are consistent with the notion that slan + cells share more functional features with monocytes (and CD16 + non-classical monocytes, in particular) than with conventional DC subsets. Therefore, we concur with Hofer and colleagues [22] and propose to allocate slan + cells to the monocyte compartment instead of the DC lineage and designate them as slan + nonclassical monocytes. Our data further indicate that these slan + non-classical monocytes are proinflammatory and may have an essential role in driving innate and secondary adaptive-immune responses, both to bacteria and viruses. These observations may also have implications for mechanisms underlying immunemediated diseases and suggest distinct roles for slan + nonclassical monocytes and conventional myeloid DC subsets in this respect. Importantly, this functional dichotomy between conventional DCs and slan + non-classical monocytes strongly suggests that they may be selectively targeted for the therapy of different inflammation-related disorders or malignancies. 
